The FDA and European approvals for Bromfenac Sodium are for use one day before and two weeks following cataract surgery for the treatment of ocular inflammation and pain. It is a nonsteroidal anti-inflammatory drug.. Reference standards of Bromfenac Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Bromfenac Sodium
Catalogue No.:PA 02 47000
CAS :
Molecular Formula : C15H11BrNNaO3
Molecular Weight : 356.15
2-Amino-3-(4-bromobenzoyl)benzoic Acid
Catalogue No.:PA 02 47510
Molecular Formula : C14H10BrNO3
Molecular Weight : 320.14
7,7'-Bis(4-bromobenzoyl)-1H,1'H-[3,3']-biindolinylidene-2,2'-dione
Catalogue No.:PA 02 47520
Molecular Formula : C30H16Br2N2O4
Molecular Weight : 628.28
7-(4-Bromobenzoyl)indolin-2-one
Catalogue No.:PA 02 47530
Molecular Formula : C15H10BrNO2
Molecular Weight : 316.15
WAY 127039-A-1
Catalogue No.:PA 02 0471000
Molecular Formula : C15H10BrNO4
Molecular Weight : 348.15
(12-Oxo-5,6,11,12-tetrahydrobenzo[6,7]azepino[4,3-b]indole-4,10-diyl)bis((4-bromophenyl)methanone)
Catalogue No.:PA 02 0471001
Molecular Formula : C30H18Br2N2O3
Molecular Weight : 614.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
